Biblio

Export 7 results:
Author Title Type [ Year(Desc)]
Filters: Author is Cummings, Jeffrey  [Clear All Filters]
2015
H. Liu-Seifert, Siemers, E., Price, K., Han, B., Selzler, K. J., Henley, D., Sundell, K., Aisen, P., Cummings, J., Raskin, J., and Mohs, R., “Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 1, pp. 205-14, 2015.
2017
J. Cummings, Scheltens, P., McKeith, I., Blesa, R., Harrison, J. E., Bertolucci, P. H. F., Rockwood, K., Wilkinson, D., Wijker, W., Bennett, D. A., and Shah, R. C., “Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1131-1139, 2017.
V. Bloniecki, Aarsland, D., Blennow, K., Cummings, J., Falahati, F., Winblad, B., and Freund-Levi, Y., “Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 57, no. 2, pp. 387-393, 2017.
Z. Ismail, Agüera-Ortiz, L., Brodaty, H., Cieslak, A., Cummings, J., Fischer, C. E., Gauthier, S., Geda, Y. E., Herrmann, N., Kanji, J., Lanctôt, K. L., Miller, D. S., Mortby, M. E., Onyike, C. U., Rosenberg, P. B., Smith, E. E., Smith, G. S., Sultzer, D. L., and Lyketsos, C., “The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.”, J Alzheimers Dis, vol. 56, no. 3, pp. 929-938, 2017.
2018
J. Cummings, Ritter, A., and Zhong, K., “Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.”, J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.
2021
J. Cummings, Schwartz, G. G., Nicholls, S. J., Khan, A., Halliday, C., Toth, P. P., Sweeney, M., Johansson, J. O., Wong, N. C. W., Kulikowski, E., Kalantar-Zadeh, K., Lebioda, K., Ginsberg, H. N., Winblad, B., Zetterberg, H., and Ray, K. K., “Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
2024
D. Gohel, Zhang, P., Gupta, A. Kumar, Li, Y., Chiang, C. - W., Li, L., Hou, Y., Pieper, A. A., Cummings, J., and Cheng, F., “Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.”, J Alzheimers Dis, vol. 98, no. 2, pp. 643-657, 2024.